# SODIUM STARCH GLYCOLATE TYPE A

URL: https://app.greenveil.ai/ingredients/ingredient_unii_h8_av0_sqx4_d
Categories: pharma
Identifier: chembl:CHEMBL2108008

> SODIUM STARCH GLYCOLATE TYPE A. Route: BUCCAL; Dosage form: TABLET; Potency: 10 mg Assessed from 18 sources.

## Safety assessment

- Chemical concern: not yet assessed
- Rationale: Route: BUCCAL; Dosage form: TABLET; Potency: 10 mg

## Regulatory status

- US: inactive ingredient database — Route: BUCCAL; Dosage form: TABLET; Potency: 10 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 540 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE, COATED PELLETS; Potency: 16.71 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE, DELAYED RELEASE; Maximum daily exposure: 110 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Maximum daily exposure: 90 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: POWDER, FOR SUSPENSION; Maximum daily exposure: 42 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET; Potency: 876 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, CHEWABLE; Maximum daily exposure: 280 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, COATED; Maximum daily exposure: 72 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, DELAYED RELEASE; Maximum daily exposure: 363 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 161 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, FILM COATED; Maximum daily exposure: 272 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, FOR SUSPENSION; Maximum daily exposure: 165 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, ORALLY DISINTEGRATING; Maximum daily exposure: 29 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE; Maximum daily exposure: 119 mg
- US: inactive ingredient database — Route: SUBLINGUAL; Dosage form: TABLET; Potency: 10 mg
- US: listed in openFDA substance — openFDA substance registry classifies this ingredient as mixture.

_Assessed by Greenveil._